{"schema":"hottub-news/story/v1","story":"st_5a6wtupcrldpvuc3ufkq","title":"Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China’s 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products","title_en":"Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China’s 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products","outlets":3,"brief":null,"page":"https://hottub.news/stories/zai-lab-announces-first-time-inclusion-of-karxt-and-vyvgart-hytrulo-in-5a6wtupcrl","count":3,"items":[{"id":"n_5a6wtupcrldpvuc3ufkq","seq":10980184,"kind":"article","title":"Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China's 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products","url":"https://www.manilatimes.net/2026/11/14/tmt-newswire/pr-newswire/zai-lab-announces-first-time-inclusion-of-karxt-and-vyvgart-hytrulo-in-chinas-2026-national-reimbursement-drug-list-expanding-access-to-key-growth-products/2469997","published":"2026-11-14T05:58:00Z","seen":"2026-11-14T06:53:00Z","lang":"en","country":"PH","source":{"id":"manilatimes.net","name":"manilatimes.net","domain":"manilatimes.net","outlet":{"wikidata":"Q1573100","name":"The Manila Times","type":"magazine","country":"PH","designations":["organization","periodical"]}},"via":"gdelt-gkg-english","topics":["economy","health","business"],"story":"st_5a6wtupcrldpvuc3ufkq","category":"economy-business","category_p":0.5699999928474426,"sentiment":"neutral","tone":0.1599999964237213,"political":0.10999999940395355},{"id":"n_bc5l5lkjhx5mouu6dopa","seq":10983289,"kind":"article","title":"Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China’s 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products","url":"https://laotiantimes.com/2026/11/14/zai-lab-announces-first-time-inclusion-of-karxt-and-vyvgart-hytrulo-in-chinas-2026-national-reimbursement-drug-list-expanding-access-to-key-growth-products","summary":"SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ — Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country’s 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings, expanding patient access to treatments for […]","published":"2026-11-14T05:38:00Z","seen":"2026-11-14T07:08:00Z","lang":"en","country":"LA","source":{"id":"kite-laotiantimes-com-d879ae","name":"laotiantimes.com","domain":"laotiantimes.com","outlet":{"wikidata":"Q114457330","name":"Laotian Times","type":"newspaper","country":"LA","designations":["newspaper"]}},"via":"kite-laotiantimes-com-d879ae","topics":["asia","cision pr newswire"],"authors":["Advertorial Desk"],"story":"st_5a6wtupcrldpvuc3ufkq","category":"economy-business","category_p":0.5699999928474426,"sentiment":"neutral","tone":0.36000001430511475,"political":0.10999999940395355},{"id":"n_uvjhwxyxlbpnlx6ea2wa","seq":10998612,"kind":"article","title":"Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China's 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products – Thailand Business News","url":"https://www.thailand-business-news.com/pr-news/zai-lab-announces-first-time-inclusion-of-karxt-and-vyvgart-hytrulo-in-chinas-2026-national-reimbursement-drug-list-expanding-access-to-key-growth-products","published":"2026-11-14T05:38:00Z","seen":"2026-11-14T08:26:56Z","lang":"en","country":"TH","source":{"id":"thailand-business-news.com","name":"thailand-business-news.com","domain":"thailand-business-news.com","outlet":{"wikidata":"Q120063840","name":"Thailand Business News","type":"newspaper","country":"TH","designations":["newspaper"]}},"via":"gdelt-gkg-english","topics":["economy","politics","health","business"],"story":"st_5a6wtupcrldpvuc3ufkq","category":"economy-business","category_p":0.699999988079071,"sentiment":"neutral","tone":0.07999999821186066,"political":0.10000000149011612}]}